Clinilabs is the leader in centralized polysomnographic (PSG) scoring. Since 2001, the Company has processed millions of pages of PSG data, and has provided centralized scoring services to multiple sponsors involved in the development of sleep therapeutics. Clinilabs’ experience includes Phase I – IV multicenter trials of therapeutics under development for the treatment of insomnia, narcolepsy, sleep apnea, restless legs syndrome, and circadian rhythm disorders.
Today’s PSGs are digital, and it takes an experienced information technology provider to manage such data. Clinilabs has one of the most robust IT infrastructures dedicated to the collection and processing of digital PSG recordings in the industry today. Data collected at investigator sites are transmitted electronically to Clinilabs’ core data center using a Web-based interface. These data are acquired and processed (scored) in a secure, 21 CFR Part 11-compliant environment, using well-developed standard operating procedures. Proven, customized, validated software applications are used to derive critical outcome variables, populate databases, and generate reports for sponsors. Clinilabs’ standards for PSG data management have been adopted by pharmaceutical companies worldwide.
As the recognized leader in visual PSG scoring, Clinilabs is at the forefront of automated scoring methods and technologies, including power spectral analysis (PSA), cyclic alternating pattern (CAP) analysis, and automatic scoring tools that enable sponsors to gain insight into their data.
|
